592 related articles for article (PubMed ID: 12749244)
1. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone.
Kao JH; Lai MY; Chen W; Chen PJ; Chen DS
J Gastroenterol Hepatol; 1998 Dec; 13(12):1249-53. PubMed ID: 9918434
[TBL] [Abstract][Full Text] [Related]
3. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
4. High initial dose combination regimen with interferon-alpha and ribavirin in chronic hepatitis C.
Kotzev I; Ivanova I; Atanassova M; Atanassova A; Glinkova V; Gancheva D; Shalev I; Manevska B; Krasnaliev I; Tomcheva S
Hepatogastroenterology; 2003; 50(50):463-6. PubMed ID: 12749248
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders.
Hasan F; Asker H; al Shamali M; al Kalaoui M; al Nakib B
Hepatogastroenterology; 2000; 47(36):1642-4. PubMed ID: 11149023
[TBL] [Abstract][Full Text] [Related]
6. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.
Sulkowski MS; Wasserman R; Brooks L; Ball L; Gish R
J Viral Hepat; 2004 May; 11(3):243-50. PubMed ID: 15117326
[TBL] [Abstract][Full Text] [Related]
7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D
Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613
[TBL] [Abstract][Full Text] [Related]
9. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
10. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P
Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
McHutchison JG; Shiffman ML; Cheung RC; Gordon SC; Wright TL; Pottage JC; McNair L; Ette E; Moseley S; Alam J
Antivir Ther; 2005; 10(5):635-43. PubMed ID: 16152757
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
[TBL] [Abstract][Full Text] [Related]
14. Therapy of hepatitis C: alpha interferon and ribavirin.
Reichard O; Schvarcz R; Weiland O
Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674
[TBL] [Abstract][Full Text] [Related]
15. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
Hamidah A; Yong JF; Zulkifli HI; Jamal R
Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
[TBL] [Abstract][Full Text] [Related]
17. Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study.
Andreone P; Cursaro C; Gramenzi A; Fiorino S; Di Giammarino L; Miniero R; D'Errico A; Grigioni WF; Gasbarrini G; Bernardi M
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):688-94. PubMed ID: 10730561
[TBL] [Abstract][Full Text] [Related]
18. Interferon and ribavirin combination therapy: indications and schedules.
Weiland O
Forum (Genova); 2000; 10(1):22-8. PubMed ID: 10717255
[TBL] [Abstract][Full Text] [Related]
19. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
Srinivas D; Mani H; Crumpler C; Van Thiel DH
Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
[TBL] [Abstract][Full Text] [Related]
20. A pilot study: longer duration of posttransplant hepatitis C virus therapy may increase the sustained response rate.
Karasu Z; Akay S; Yilmaz F; Akarca U; Ersoz G; Gunsar F; Kilic M
Transplant Proc; 2009 Nov; 41(9):3806-9. PubMed ID: 19917392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
